Characterization of myocardial oxidative metabolism and myocardial external efficiency in high-risk alcohol cardiotoxicity and alcoholic cardiomyopathy via dynamic
11C-Acetate
Myocardial oxidative metabolism
PET/CT
alcoholic cardiomyopathy
myocardial blood flow
myocardial external efficiency
myocardial oxygen consumption
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
03
03
2020
accepted:
06
05
2020
pubmed:
20
6
2020
medline:
30
4
2022
entrez:
20
6
2020
Statut:
ppublish
Résumé
The purpose of this study was to evaluate subjects with high-risk alcohol cardiotoxicity and patients with alcoholic cardiomyopathy (ACM) via dynamic We recruited 37 subjects with chronic alcohol consumption [18 with moderate consumption (MC), 19 with heavy consumption (HC)], 5 ACM patients, and 12 healthy controls to receive dynamic Functional assessment via dynamic
Identifiants
pubmed: 32557237
doi: 10.1007/s12350-020-02214-0
pii: 10.1007/s12350-020-02214-0
doi:
Substances chimiques
Acetates
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
278-288Informations de copyright
© 2020. American Society of Nuclear Cardiology.
Références
Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol 2014;6:771-81.
doi: 10.4330/wjc.v6.i8.771
Piano MR, Phillips SA. Alcoholic cardiomyopathy: Pathophysiologic insights. Cardiovasc Toxicol 2014;14:291-308.
doi: 10.1007/s12012-014-9252-4
Cunningham CC, Spach PI. Alcoholism and myocardial energy metabolism. Alcohol Clin Exp Res 1994;18:132-7.
doi: 10.1111/j.1530-0277.1994.tb00892.x
Brown M, Marshall DR, Sobel BE, Bergmann SR. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 1987;76:687-96.
doi: 10.1161/01.CIR.76.3.687
Naya M, Tamaki N. Imaging of myocardial oxidative metabolism in heart failure. Curr Cardiovasc Imaging Rep 2014;7:9244.
doi: 10.1007/s12410-013-9244-y
Harms HJ, Hansson NHS, Kero T, Baron T, Tolbod LP, Kim WY, et al. Automatic calculation of myocardial external efficiency using a single
Haseeb S, Alexander B, Baranchuk A. Wine and cardiovascular health: A comprehensive review. Circulation 2017;136:1434-48.
doi: 10.1161/CIRCULATIONAHA.117.030387
Huo L, Guo J, Dang Y, Lv J, Zheng Y, Li F, et al. Kinetic analysis of dynamic
doi: 10.7150/thno.10760
Timmer SA, Lubberink M, Germans T, Gotte MJ, ten Berg JM, ten Cate FJ, et al. Potential of [
doi: 10.1007/s12350-009-9181-y
van den Hoff J. Methodologic aspects of myocardial blood flow quantification with 1-
Sciacca RR, Akinboboye O, Chou RL, Epstein S, Bergmann SR. Measurement of myocardial blood flow with PET using 1-
Wu YW, Naya M, Tsukamoto T, Komatsu H, Morita K, Yoshinaga K, et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J Off J Jpn Circ Soc 2008;72:786-92.
Knuuti J, Sundell J, Naum A, Engblom E, Koistinen J, Ylitalo A, et al. Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy. Eur J Nucl Med Mol Imaging 2004;31:1592-8.
doi: 10.1007/s00259-004-1631-9
Stolen KQ, Kemppainen J, Ukkonen H, Kalliokoski KK, Luotolahti M, Lehikoinen P, et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003;41:460-7.
doi: 10.1016/S0735-1097(02)02772-9
Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJ, Visser CA, et al. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med 2001;28:651-68.
doi: 10.1007/s002590000472
Kronenberg MW, Cohen GI, Leonen MF, Mladsi TA, Di Carli MF. Myocardial oxidative metabolic supply–demand relationships in patients with nonischemic dilated cardiomyopathy. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2006;13:544-53.
Beanlands RS, Bach DS, Raylman R, Armstrong WF, Wilson V, Montieth M, et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 1993;22:1389-98.
doi: 10.1016/0735-1097(93)90548-F
Affo S, Yu LX, Schwabe RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol 2017;12:153-86.
doi: 10.1146/annurev-pathol-052016-100322
Kino M, Imamitchi H, Morigutchi M, Kawamura K, Takatsu T. Cardiovascular status in asymptomatic alcoholics, with reference to the level of ethanol consumption. Br Heart J 1981;46:545-51.
doi: 10.1136/hrt.46.5.545
Mathews EC Jr, Gardin JM, Henry WL, Del Negro AA, Fletcher RD, Snow JA, et al. Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol 1981;47:570-8.
doi: 10.1016/0002-9149(81)90540-3
Maisch B. Alcoholic cardiomyopathy: The result of dosage and individual predisposition. Herz 2016;41:484-93.
doi: 10.1007/s00059-016-4469-6
Fernandez-Sola J, Planavila Porta A. New treatment strategies for alcohol-induced heart damage. Int J Mol Sci 2016;17:1651.
doi: 10.3390/ijms17101651
Bryson CL, Mukamal KJ, Mittleman MA, Fried LP, Hirsch CH, Kitzman DW, et al. The association of alcohol consumption and incident heart failure: The Cardiovascular Health Study. J Am Coll Cardiol 2006;48:305-11.
doi: 10.1016/j.jacc.2006.02.066